Company Description
FAREVA is a global pharmaceutical CDMO with industry leading capabilities in the development and manufacturing of a large range of Drug Products and Active Pharmaceutical Ingredients (APIs).
Company Background
FAREVA employs 13,000 people distributed in 41 production sites located in 13 countries in EMEA and the Americas. 16 of the FAREVA sites (including the latest acquisitions) are dedicated to pharmaceutical activities.
Facilities
FAREVA’s API division has operations in 3 European sites located in France and Germany: Fareva Excella, Fareva Valdepharm, Fareva LaVallée.
Services and Capabilities
We offer the development and manufacturing of highly potent APIs at level OEB 4 to OEB 6 from early clinical phase all the way to market approval and commercial. Production quantities can be from 100 g to multi-ton scale with worldwide accreditations and certifications for quality, EHS and sustainability.
Furthermore, we provide sterile API manufacturing in a fully automated facility. Sterile filtration, crystallization and micronization are available.
Spray drying of APIs is another expertise and available up to OEB 4 level. Equipment is made of Hastelloy, built to resist highly corrosive products.
The CDMO service of Fareva includes complete API development and manufacturing services, from a few hundred grams to multi-ton quantities. We provide full analytical and regulatory support.
The Generic API portfolio consists of 30+ generic products containing conventional & high potent APIs as well as hormones and steroids.